{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:04:05Z","timestamp":1782846245057,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This work was supported by the Vice-Chancellor for Research at Mashhad University of Medical Sciences","award":["4010615"],"award-info":[{"award-number":["4010615"]}]},{"name":"This work was supported by the Vice-Chancellor for Research at Mashhad University of Medical Sciences","award":["4010615"],"award-info":[{"award-number":["4010615"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00520-025-09649-6","type":"journal-article","created":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T16:53:01Z","timestamp":1751820781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Introducing equivalent and threshold doses in the assessment of medication-related osteonecrosis of the jaw risk: insights from a descriptive study in Iran"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0996-1193","authenticated-orcid":false,"given":"Pegah","family":"Mosannen Mozafari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1189-3276","authenticated-orcid":false,"given":"Leila","family":"Farhad Molashahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4797-8714","authenticated-orcid":false,"given":"Maliheh","family":"Dadgarmoghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4580-9463","authenticated-orcid":false,"given":"Seyedeh Vajiheh","family":"Kazemian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7206-8854","authenticated-orcid":false,"given":"Amirreza","family":"Nabavi Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4596-108X","authenticated-orcid":false,"given":"Pooria","family":"Aghassizadeh Sharbaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9324-381X","authenticated-orcid":false,"given":"Sajedeh","family":"Sheikhi Azghandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5793-0165","authenticated-orcid":false,"given":"Parham","family":"Aghassizadeh Sharbaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6393-3559","authenticated-orcid":false,"given":"Reid","family":"Friesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5196-7631","authenticated-orcid":false,"given":"Eduardo Rodrigues","family":"Fregnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,6]]},"reference":[{"key":"9649_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2022.02.008","author":"SL Ruggiero","year":"2022","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D (2022) American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws-2022 update. J Oral Maxillofac Surg. https:\/\/doi.org\/10.1016\/j.joms.2022.02.008","journal-title":"J Oral Maxillofac Surg"},{"key":"9649_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2023.08.241","author":"V Patel","year":"2023","unstructured":"Patel V, Carey B (2023) Pembrolizumab-related osteonecrosis of the jaw. Br J Oral Maxillofac Surg. https:\/\/doi.org\/10.1016\/j.bjoms.2023.08.241","journal-title":"Br J Oral Maxillofac Surg"},{"key":"9649_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/5544285","author":"L Sisalli","year":"2023","unstructured":"Sisalli L, Giordano F, Chiacchio A, Acerra A, Caggiano M (2023) Medication-related osteonecrosis of the jaw: a case report of an unusual side effect of adalimumab. Case Rep Dent. https:\/\/doi.org\/10.1155\/2023\/5544285","journal-title":"Case Rep Dent"},{"issue":"1","key":"9649_CR4","first-page":"1","volume":"6","author":"PM Mozafari","year":"2023","unstructured":"Mozafari PM, Farrokhie ZS, Nahayati MA, Anbiaee N (2023) Medication-related osteonecrosis of the jaw (MRONJ) as a consequence of multiple sclerosis treatment. Clin Oral Sci Dent 6(1):1\u20136","journal-title":"Clin Oral Sci Dent"},{"key":"9649_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-018-4501-x","author":"O Nicolatou-Galitis","year":"2019","unstructured":"Nicolatou-Galitis O, Kouri M, Papadopoulou E, Vardas E, Galiti D, Epstein JB et al (2019) Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review. Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-018-4501-x","journal-title":"Support Care Cancer"},{"key":"9649_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol31010016","author":"LD Sen\u00edn","year":"2024","unstructured":"Sen\u00edn LD, Pancorbo DM, Garc\u00e9s MYR, Santos-Rubio MD, Calero JB (2024) Relationship between medication-related osteonecrosis of the jaw and CDK4\/6 inhibitors in breast cancer. Curr Oncol. https:\/\/doi.org\/10.3390\/curroncol31010016","journal-title":"Curr Oncol"},{"key":"9649_CR7","doi-asserted-by":"publisher","unstructured":"Ahdi H, Wichelmann TA, Pandravada S, Ehrenpreis E (2024) Osteonecrosis of the Jaw (ONJ) Associated with bevacizumab: a case series from the FDA Adverse Event Reporting System (FAERS) database. https:\/\/doi.org\/10.21203\/rs.3.rs-4088785\/v1","DOI":"10.21203\/rs.3.rs-4088785\/v1"},{"key":"9649_CR8","doi-asserted-by":"publisher","unstructured":"Schifter M, McLean M, Sukumar S (2021) Disorders of the endocrine system and of metabolism. In: Burket\u2019s oral medicine. Wiley, New York, pp 817\u2013902. https:\/\/doi.org\/10.1002\/9781119597797.ch22","DOI":"10.1002\/9781119597797.ch22"},{"key":"9649_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2009.03.050","author":"JC Lo","year":"2010","unstructured":"Lo JC, O\u2019Ryan F, Gordon NP, Yang J, Hui RL, Martin DC et al (2010) Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg. https:\/\/doi.org\/10.1016\/j.joms.2009.03.050","journal-title":"J Oral Maxillofac Surg"},{"key":"9649_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-020-05440-x","author":"L Drudge-Coates","year":"2020","unstructured":"Drudge-Coates L, Van den Wyngaert T, Schi\u00f8dt M, Van Muilekom H, Demonty G, Otto S (2020) Preventing, identifying, and managing medication-related osteonecrosis of the jaw: a practical guide for nurses and other allied healthcare professionals. Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-020-05440-x","journal-title":"Support Care Cancer"},{"key":"9649_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e03795","author":"C Ottesen","year":"2020","unstructured":"Ottesen C, Schi\u00f8dt M, Gotfredsen K (2020) Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): a systematic review. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03795","journal-title":"Heliyon"},{"key":"9649_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2018.09.008","author":"O Nicolatou-Galitis","year":"2019","unstructured":"Nicolatou-Galitis O, Schi\u00f8dt M, Mendes RA, Ripamonti C, Hope S, Drudge-Coates L et al (2019) Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol. https:\/\/doi.org\/10.1016\/j.oooo.2018.09.008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"9649_CR13","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b15-00385","author":"M Kajizono","year":"2015","unstructured":"Kajizono M, Sada H, Sugiura Y, Soga Y, Kitamura Y, Matsuoka J, Sendo T (2015) Incidence and risk factors of osteonecrosis of the jaw in advanced cancer patients after treatment with zoledronic acid or denosumab: a retrospective cohort study. Biol Pharm Bull. https:\/\/doi.org\/10.1248\/bpb.b15-00385","journal-title":"Biol Pharm Bull"},{"key":"9649_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2020.12.045","author":"Z Feng","year":"2021","unstructured":"Feng Z, An J, Zhang Y (2021) Factors influencing severity of medication-related osteonecrosis of the jaw: A retrospective study. J Oral Maxillofac Surg. https:\/\/doi.org\/10.1016\/j.joms.2020.12.045","journal-title":"J Oral Maxillofac Surg"},{"key":"9649_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e03795","author":"MH Kang","year":"2018","unstructured":"Kang MH, Lee DK, Kim CW, Song IS, Jun SH (2018) Clinical characteristics and recurrence-related factors of medication-related osteonecrosis of the jaw. J Korean Assoc Oral Maxillofac Surg. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03795","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"9649_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr435","author":"F Saad","year":"2012","unstructured":"Saad F, Brown JE, Van Poznak C, Ibrahim T, Stemmer SM, Stopeck A et al (2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol. https:\/\/doi.org\/10.1093\/annonc\/mdr435","journal-title":"Ann Oncol"},{"key":"9649_CR17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.2768","author":"A Kyrgidis","year":"2008","unstructured":"Kyrgidis A, Vahtsevanos K, Koloutsos G, Andreadis C, Boukovinas I, Teleioudis Z et al (2008) Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2008.16.2768","journal-title":"J Clin Oncol"},{"key":"9649_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijom.2012.06.020","author":"T Yamazaki","year":"2012","unstructured":"Yamazaki T, Yamori M, Ishizaki T, Asai K, Goto K, Takahashi K et al (2012) Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study. Int J Oral Maxillofac Surg. https:\/\/doi.org\/10.1016\/j.ijom.2012.06.020","journal-title":"Int J Oral Maxillofac Surg"},{"key":"9649_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2013.02.016","author":"C Tsao","year":"2014","unstructured":"Tsao C, Darby I, Ebeling PR, Walsh K, O\u2019Brien-Simpson N, Reynolds E, Borromeo G (2014) Oral health risk factors for bisphosphonate-associated jaw osteonecrosis. J Oral Maxillofac Surg. https:\/\/doi.org\/10.1016\/j.joms.2013.02.016","journal-title":"J Oral Maxillofac Surg"},{"key":"9649_CR20","doi-asserted-by":"publisher","DOI":"10.4317\/medoral.24318","author":"V Fusco","year":"2021","unstructured":"Fusco V, Cabras M, Erovigni F, Dell\u2019Acqua A, Arduino PG, Pentenero M et al (2021) A multicenter observational study on medication-related osteonecrosis of the jaw (MRONJ) in advanced cancer and myeloma patients of a cancer network in North-Western Italy. Med Oral Patol Oral Cir Bucal. https:\/\/doi.org\/10.4317\/medoral.24318","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"9649_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20011101)92:9<2419::AID-CNCR1591>3.0.CO;2-K","author":"A Banfi","year":"2001","unstructured":"Banfi A, Podest\u00e0 M, Fazzuoli L, Sertoli MR, Venturini M, Santini G et al (2001) High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia. Cancer. https:\/\/doi.org\/10.1002\/1097-0142(20011101)92:9%3c2419::AID-CNCR1591%3e3.0.CO;2-K","journal-title":"Cancer"},{"key":"9649_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4021952","author":"G Oteri","year":"2018","unstructured":"Oteri G, Campisi G, Panzarella V, Morreale I, Nucera R, Di Fede O et al (2018) Could the combined administration of bone antiresorptive drug, taxanes, and corticosteroids worsen medication-related osteonecrosis of the jaws in cancer patients? Biomed Res Int. https:\/\/doi.org\/10.1155\/2018\/4021952","journal-title":"Biomed Res Int"},{"key":"9649_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5847429","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Yu Y, Shi Y, Li M, Yang C, Wang S (2020) Combined administration of bisphosphonates, chemotherapeutic agents, and\/or targeted drugs increases the risk for stage 3 medication-related osteonecrosis of the jaw: a 4-year retrospective study. Biomed Res Int. https:\/\/doi.org\/10.1155\/2020\/5847429","journal-title":"Biomed Res Int"},{"key":"9649_CR24","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200831050-00001","author":"K Shim","year":"2008","unstructured":"Shim K, MacKenzie MJ, Winquist E (2008) Chemotherapy-associated osteonecrosis in cancer patients with solid tumours: a systematic review. Drug Saf. https:\/\/doi.org\/10.2165\/00002018-200831050-00001","journal-title":"Drug Saf"},{"key":"9649_CR25","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.090592","author":"Y Bi","year":"2010","unstructured":"Bi Y, Gao Y, Ehirchiou D, Cao C, Kikuiri T, Le A et al (2010) Bisphosphonates cause osteonecrosis of the jaw-like disease in mice. Am J Pathol. https:\/\/doi.org\/10.2353\/ajpath.2010.090592","journal-title":"Am J Pathol"},{"key":"9649_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10204762","author":"A Marcian\u00f2","year":"2021","unstructured":"Marcian\u00f2 A, Ingrasciotta Y, Isgr\u00f2 V, L\u2019Abbate L, Foti SS, Picone A et al (2021) Cancer patients at risk for medication-related osteonecrosis of the jaw: a case and control study analyzing predictors of MRONJ onset. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10204762","journal-title":"J Clin Med"},{"key":"9649_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2014.04.031","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O\u2019Ryan F (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update. J Oral Maxillofac Surg. https:\/\/doi.org\/10.1016\/j.joms.2014.04.031","journal-title":"J Oral Maxillofac Surg"},{"key":"9649_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cells12202430","author":"I Roato","year":"2023","unstructured":"Roato I, Pavone L, Pedraza R, Bosso I, Baima G, Erovigni F, Mussano F (2023) Denosumab and zoledronic acid differently affect circulating immune subsets: a possible role in the onset of MRONJ. Cells. https:\/\/doi.org\/10.3390\/cells12202430","journal-title":"Cells"},{"key":"9649_CR29","doi-asserted-by":"publisher","DOI":"10.4317\/medoral.23324","author":"A Limones","year":"2020","unstructured":"Limones A, S\u00e1ez-Alcaide LM, D\u00edaz-Parre\u00f1o SA, Helm A, Bornstein MM, Molinero-Mourelle P (2020) Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab vs zoledronic acid: a systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. https:\/\/doi.org\/10.4317\/medoral.23324","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"9649_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2020.04.808","author":"F Hallmer","year":"2020","unstructured":"Hallmer F, Bjarnadottir O, G\u00f6trick B, Malmstr\u00f6m P, Andersson G (2020) Incidence of and risk factors for medication-related osteonecrosis of the jaw in women with breast cancer with bone metastasis: a population-based study. Oral Surg Oral Med Oral Pathol Oral Radiol. https:\/\/doi.org\/10.1016\/j.oooo.2020.04.808","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"9649_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-021-06018-x","author":"H Ikesue","year":"2021","unstructured":"Ikesue H, Mouri M, Tomita H, Hirabatake M, Ikemura M, Muroi N et al (2021) Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases. Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-021-06018-x","journal-title":"Support Care Cancer"},{"key":"9649_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-020-05882-3","author":"A Srivastava","year":"2021","unstructured":"Srivastava A, Nogueras Gonzalez GM, Geng Y, Won AM, Cabanillas ME, Naing A et al (2021) Prevalence of medication-related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis. Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-020-05882-3","journal-title":"Support Care Cancer"},{"key":"9649_CR33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.21.9584","author":"K Vahtsevanos","year":"2009","unstructured":"Vahtsevanos K, Kyrgidis A, Verrou E, Katodritou E, Triaridis S, Andreadis C et al (2009) Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2009.21.9584","journal-title":"J Clin Oncol"},{"key":"9649_CR34","doi-asserted-by":"publisher","DOI":"10.5125\/jkaoms.2017.43.1.16","author":"YH Kim","year":"2017","unstructured":"Kim YH, Park HK, Choi NR, Kim SW, Kim GC, Hwang DS et al (2017) Relationship between disease stage and renal function in bisphosphonate-related osteonecrosis of the jaw. J Korean Assoc Oral Maxillofac Surg. https:\/\/doi.org\/10.5125\/jkaoms.2017.43.1.16","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"9649_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2016.06.003","author":"LL Graves","year":"2016","unstructured":"Graves LL, Bukata SV, Aghazadehsanai N, Chang TI, Garrett NR, Friedlander AH (2016) Patients receiving parenteral bisphosphonates for malignant disease and having developed an atypical femoral fracture are at risk of concomitant osteonecrosis of the jaw: an evidence-based review. J Oral Maxillofac Surg. https:\/\/doi.org\/10.1016\/j.joms.2016.06.003","journal-title":"J Oral Maxillofac Surg"},{"key":"9649_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/SCS.0000000000009033","author":"S Yao","year":"2023","unstructured":"Yao S, Ding X, Rong G, Zhou J, Zhang B (2023) Association between malignant diseases and medication-related osteonecrosis of the jaw (MRONJ): a systematic review and meta-analysis. J Craniofac Surg. https:\/\/doi.org\/10.1097\/SCS.0000000000009033","journal-title":"J Craniofac Surg"},{"key":"9649_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132988","author":"HW Kim","year":"2021","unstructured":"Kim HW, Lee MW, Lee JH, Kim MY (2021) Comparison of the effect of oral versus intravenous bisphosphonate administration on osteoclastogenesis in advanced-stage medication-related osteonecrosis of the jaw patients. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10132988","journal-title":"J Clin Med"},{"key":"9649_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2022.04.049","author":"Z Feng","year":"2022","unstructured":"Feng Z, An J, He Y, Zhang Y (2022) A comparative study of the clinical characteristics of patients with medication-related osteonecrosis of the jaw and osteoporosis or malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. https:\/\/doi.org\/10.1016\/j.oooo.2022.04.049","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"9649_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2017.05.028","author":"S Aljohani","year":"2017","unstructured":"Aljohani S, Fliefel R, Ihbe J, K\u00fchnisch J, Ehrenfeld M, Otto S (2017) What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: a systematic review. J Cranio-Maxillofac Surg. https:\/\/doi.org\/10.1016\/j.jcms.2017.05.028","journal-title":"J Cranio-Maxillofac Surg"},{"key":"9649_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-020-05556-0","author":"TL Ng","year":"2021","unstructured":"Ng TL, Tu MM, Ibrahim MFK, Basulaiman B, McGee SF, Srikanthan A et al (2021) Long-term impact of bone-modifying agents for the treatment of bone metastases: A systematic review. Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-020-05556-0","journal-title":"Support Care Cancer"},{"key":"9649_CR41","unstructured":"Zakhary I, Khanafer A, Mirkhani M (2017) Idiopathic incidence of MRONJ in patients on denosumab. Clin Surg 2:1410"},{"key":"9649_CR42","doi-asserted-by":"publisher","unstructured":"de Oliveira CC, de Sousa FB (2016) Osteonecrosis of the jaw induced by receptor activator of nuclear factor-kappa B ligand (denosumab)-review. Med Oral Patol Oral Cir Bucal. https:\/\/doi.org\/10.4317\/medoral.21044","DOI":"10.4317\/medoral.21044"},{"key":"9649_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2017.05.027","author":"M Zirk","year":"2017","unstructured":"Zirk M, Kreppel M, Buller J, Pristup J, Peters F, Dreiseidler T, Zinser M, Z\u00f6ller JE (2017) The impact of surgical intervention and antibiotics on MRONJ stage II and III: a retrospective study. J Cranio-Maxillofac Surg. https:\/\/doi.org\/10.1016\/j.jcms.2017.05.027","journal-title":"J Cranio-Maxillofac Surg"},{"key":"9649_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/app13074370","author":"AM Inchingolo","year":"2023","unstructured":"Inchingolo AM, Malcangi G, Ferrara I, Patano A, Viapiano F, Netti A et al (2023) MRONJ treatment strategies: a systematic review and two case reports. Appl Sci. https:\/\/doi.org\/10.3390\/app13074370","journal-title":"Appl Sci"},{"key":"9649_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jds.2017.12.003","author":"Q Wang","year":"2018","unstructured":"Wang Q, Liu J, Qi S, Liao X, Liu D, Pan J (2018) Clinical analysis of medication-related osteonecrosis of the jaws: a growing severe complication in China. J Dent Sci. https:\/\/doi.org\/10.1016\/j.jds.2017.12.003","journal-title":"J Dent Sci"},{"key":"9649_CR46","doi-asserted-by":"publisher","unstructured":"Wei LY, Cheng YW, Wei\u2010Yih K, Sang\u2010Heng C, Hao\u2010Hong C, Shih\u2010Jung et al (2025) Risk factors influencing medication\u2010related osteonecrosis of the jaws (MRONJ) following dental extraction among osteoporotic patients in Taiwan. Head & Neck. https:\/\/doi.org\/10.1002\/hed.28011","DOI":"10.1002\/hed.28011"},{"key":"9649_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08974-6","author":"C Moon","year":"2024","unstructured":"Moon C, Kim H, Park J, Park W, Kim H, Jun J, Young-Soo K et al (2024) High-dose denosumab (Xgeva\u00ae) associated medication-related osteonecrosis of the jaws (MRONJ): incidence and clinical characteristics in a retrospective analysis of 1278 patients. Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-024-08974-6","journal-title":"Support Care Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09649-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09649-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09649-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T04:05:16Z","timestamp":1753934716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09649-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["9649"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09649-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5922241\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Mashhad University of Medical Sciences on August 31, 2022, under grant number 4010615 and code 1401.065 IR.MUMS.DENTISTRY.REC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"PMM serves as the Scientific Mentor at Shahab Clinic. SS and Parham Aghasizadeh Sharbaf are research assistant at Shahab Clinic. Other authors have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"661"}}